Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Yamashita, Masayuki Watanabe, S. Mine, T. Kurogochi, A. Okamura, M. Hayami, Y. Imamura (2017)
Patterns and Outcomes of Recurrent Esophageal Cancer After Curative EsophagectomyWorld Journal of Surgery, 41
A. Wong, M. Shao, J. Rineer, Anna Lee, D. Schwartz, D. Schreiber (2017)
The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal CarcinomaAnnals of Surgery, 265
R. Kobayashi, H. Yamashita, K. Okuma, K. Shiraishi, K. Ohtomo, K. Nakagawa (2014)
Salvage radiation therapy and chemoradiation therapy for postoperative locoregional recurrence of esophageal cancer.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 27 1
C. Compton, D. Byrd, J. García-Aguilar, S. Kurtzman, A. Olawaiye, M. Washington (2012)
Esophagus and Esophagogastric Junction
(2009)
Esophagus and esophagogastric junction. AJCC Cancer Staging Manual 7th ed
(2017)
Phase II trial of intensity-modulated radiotherapy concurrentwithchemotherapy forpostoperativenode-positive esophageal squamous cell carcinoma
Z. Xiao, Zong-yi Yang, Jun Liang, Y. Miao, Mei Wang, W. Yin, X. Gu, De-chao Zhang, Ru Zhang, Liang-jun Wang (2003)
Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients.The Annals of thoracic surgery, 75 2
D. Schreiber, J. Rineer, D. Vongtama, A. Wortham, P. Han, D. Schwartz, Kwang Choi, M. Rotman (2010)
Impact of Postoperative Radiation after Esophagectomy for Esophageal CancerJournal of Thoracic Oncology, 5
Jin-Cheng Lu, C. Kong, H. Tao (2010)
Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma.International journal of radiation oncology, biology, physics, 78 3
K. Jingu, Y. Niibe, H. Yamashita, K. Katsui, Toshihiko Matsumoto, T. Nishina, A. Terahara (2017)
Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional studyRadiation Oncology (London, England), 12
Junqiang Chen, Jianji Pan, Xiong-wei Zheng, K. Zhu, Jiancheng Li, Mingqiang Chen, Jie-zhong Wang, Z. Liao (2012)
Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.International journal of radiation oncology, biology, physics, 82 1
H. Yamashita, K. Jingu, Y. Niibe, K. Katsui, Toshihiko Matsumoto, T. Nishina, A. Terahara (2017)
Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patientsRadiation Oncology (London, England), 12
(2015)
Concurrent radiotherapy andweekly chemotherapy of 5-fluorouracil and platinum agents for postoperative locoregional recurrence of oesophageal squamous cell carcinoma
AbstractTo evaluate the efficacy of salvage radiochemotherapy (SRC) in patients with recurrent lymph node after radical surgery in esophageal cancer.This study enrolled 58 patients with esophageal squamous cell carcinoma who underwent SRC for lymph node recurrence after radical surgery from August 2011 to November 2015 at our hospital. Survival rates were calculated by the Kaplan–Meier method with the log-rank test. Multivariate analysis was conducted using the Cox model.The overall 1-, 3-, and 5-year survival rates after radical surgery were 94.8%, 53.0%, and 29.6%, respectively. The 1- and 3-year survival rates after SRC were 68.7% and 26.9%, respectively. The major acute toxicities were esophagitis and neutropenia, while most toxicities were grade 1 or 2. There was no unexpected increase in serious adverse events or treatment-related deaths. The results of multivariate analysis showed that time to recurrence (odds ratio [OR]: 0.25, 95% confidence interval [CI]: 0.11–0.53, P = .0004), T stage (OR: 2.75, 95%CI: 1.16–6.49, P = .021), and prophylactic radiotherapy/chemotherapy (PRC, OR: 0.39, 95%CI: 0.16–0.98, P = .045) were determinants of postoperative overall survival, and PRC was the only factor affecting the outcome of SRC (OR: 0.28, 95%CI: 0.12–0.70, P = .006).SRC is an effective treatment for recurrent lymph node after radical surgery of esophageal cancer.
Medicine – Wolters Kluwer Health
Published: Feb 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.